Related Experiment Video
Updated: Jun 15, 2026

Microelectrode Array Recording of Sinoatrial Node Firing Rate to Identify Intrinsic Cardiac Pacemaking Defects in Mice
Published on: July 5, 2021
Genetics of Brugada syndrome
Oscar Campuzano1, Ramon Brugada, Anna Iglesias
1Cardiovascular Genetics Center UdG-IDIBGi, School of Medicine, University of Girona, Girona, Spain.
Purpose Of Review:
The Brugada syndrome has been investigated in depth since its description in 1992 both on a clinical and on a basic research level. Since the discovery of the first genetic defect in 1998, several genes have been subsequently identified. However, to date all these genes together explain only 30% of the cases, indicating that there is still an important amount of work to be done to totally unravel the genetic basis of this lethal disease. In the present study, we will focus on recent achievements in the genetic basis of this disease.
Recent Findings:
In 2009, several additional genetic mutations have been associated with the disease. Additionally, a common variant has been described as a genetic modulator of Brugada syndrome among carriers of a SCN5A mutation.
Summary:
The number of scientific publications dealing with the syndrome has continued to increase substantially in recent years. New polymorphisms, mutations and genes associated with the disease have been described. However, despite the advances, knowledge of the genetic determinants of the Brugada syndrome remains limited.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
Incomplete Dominance
Principles of Pharmacogenetics: Types of Genetic Variants
Mechanism of Cardiac Arrhythmias
Genetic Lingo
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Cardiomyopathy III: Hypertrophic Cardiomyopathy